MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Computerized cognitive test profile of 100 patients with and without Amyloid beta 1-42 burden

    F. Waga, I. Liepelt-Scarfone, M. Bentele, W. Maetzler, S. Becker, M. Timmers, L. van Nueten, G. Salvadore, K. Brockmann, M. Hobert, J. Streffer, D. Berg (Titusville, NJ, USA)

    Objective: To investigate whether a computerized neuropsychological assessment can detect subtle cognitive impairment associated with Aβ pathology in Parkinson’s disease (PD). Background: Parenchymal Aβ pathology…
  • 2019 International Congress

    Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

    M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

    Objective: To study the effect of SLC6A3VNTR on PD patients’ cognition longitudinally. Background: Solute carrier family 6 neurotransmitter transporter dopamine member 3gene (SLC6A3) has two common…
  • 2019 International Congress

    Relationship between eye movements during natural reading and basic oculomotor tasks in PD

    J. Waldthaler, L. Stock, C. Krüger-Zechlin, L. Timmermann (Marburg, Germany)

    Objective: To investigate the relationship of eye movement characteristics during natural, self-paced reading and basic visually-guided saccades (VGS) and antisaccades (AS) tasks in PD. Background:…
  • 2019 International Congress

    Tracking cortical changes throughout cognitive decline in Parkinson’s disease: a longitudinal MRI study

    E. Canu, F. Agosta, T. Stojković, S.. Basaia, I. Stankovic, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

    Objective: To investigate longitudinal cortical thinning (CT) in Parkinson’s disease (PD) patients with normal cognition (PD-CN), stable mild cognitive impairment (PD-MCIs), and patients who convert…
  • 2019 International Congress

    Pre-frontal activation during walking in Parkinson’s disease: the impact of attention

    S. Stuart, A. Giritharan, J. Quinn, M. Mancini (Portland, OR, USA)

    Objective: This study aimed to; 1) examine pre-frontal cortex (PFC) activation during walking in response to increased attentional load (dual-task) in Parkinson’s disease (PD); and…
  • 2019 International Congress

    Freezing of Gait in Parkinson’s Disease: Risk Factors and Associated Nonmotor Symptoms

    D. Lichter, L. Hershey (Buffalo, NY, USA)

    Objective: To clarify risk factors for, and clinical associations of, freezing of gait (FOG) in Parkinson's disease (PD). Background: FOG is a disabling and incompletely…
  • 2019 International Congress

    Functional exam findings in Lewy Body Disease

    J. Nguyen, K. Papesh (Las Vegas, NV, USA)

    Objective: Case study to review functional exam findings in an abnormal Dopaminergic transporter scan positive Lewy body dementia patient. Background: Patient presented with known Parkinson’s…
  • 2019 International Congress

    Genomic variants associated with cognitive impairment in Parkinson’s disease: Ethnicity-specific GWAS

    SJ. Chung, N. Choi, J. Kim, K. Kim, MJ. Kim, YJ. Kim, HS. Ryu, KW. Park (Anyang, Republic of Korea)

    Objective: We aimed to identify the genomic variants that are associated with cognitive impairment in patients with Parkinson’s disease (PD). Background: Cognitive impairment is an…
  • 2019 International Congress

    Parkinsonism and rapidly progressive dementia secondary to free-living ameba

    M. Rubio Hernandez, I. Rodriguez Leyva, M. Tello Zavala, A. Ortiz Alvarez, C. Gallegos Rios (San Luis Potosi, Mexico)

    Objective: Present an original case description of a patient with amebic meningoencephalitis. Background: Parkinsonism could be caused by degenerative disorders, brain injuries, drugs, toxins, and…
  • 2019 International Congress

    Social Cognition, Neuropsychological functioning & Mood Disorder in Cervical Dystonia (CD)

    R. Monaghan, D. Mccormack, I. Ndukwe, T. Burke, N. Pender, S. O’Riordan, M. Hutchinson, F. O'Keeffe (Dublin, Ireland)

    Objective: This study investigated social cognition, neuropsychological functioning and mood disorder in CD. Background: CD is a hyperkinetic movement disorder of unknown cause. Although historically…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley